Related Experiment Video
Updated: Aug 14, 2026

03:47
Enhancement of Facial Rejuvenation Through a Combination of 1565 nm Non-Ablative Fractional Laser with 30% Supramolecular Salicylic Acid
Published on: September 27, 2024
Klotho Protein as a Topical Therapy for Facial Photoaging Using Combined Delivery Technologies
Steve G Yoelin1, Margaret Xu1, Justine C Lam1
1From the Medical Associates, Inc., Newport Beach, CA.
Plastic and Reconstructive Surgery. Global Open
|August 13, 2026
Summary
This study shows that a 3-product topical Klotho regimen significantly improves visible signs of photoaging, including wrinkles and discoloration, within 16 weeks. The anti-aging treatment was well-tolerated and demonstrated progressive skin benefits.
Area of Science:
- Dermatology
- Anti-aging research
- Molecular biology
Background:
- Klotho, a protein associated with longevity, exhibits anti-aging properties by combating oxidative stress and maintaining cellular balance.
- In vitro studies demonstrated Klotho's ability to reduce UV-induced DNA damage and enhance skin cell longevity markers.
- This research investigated the synergistic effects of a multi-product Klotho regimen on visible skin aging.
Purpose of the Study:
- To evaluate the efficacy of a combined topical Klotho regimen in improving visible signs of facial photoaging.
- To assess the impact of the Klotho treatment on specific photodamage parameters such as dyschromia, wrinkles, and skin texture.
- To determine the safety and tolerability of the 3-product Klotho regimen over a 16-week period.
Main Methods:
- An open-label, 16-week study was conducted on adults aged 25-75 with Fitzpatrick skin types I-IV and mild to severe facial photodamage.
- Participants applied a daily regimen consisting of a face serum (25%), eye serum (15%), and night cream (10%), all containing Klotho.
- Clinical photodamage scales, along with assessments for dyschromia, erythema, dryness, peeling, lines/wrinkles, and atrophy, were used to measure outcomes.
Main Results:
- Significant improvement in overall facial photodamage was observed, with an average reduction of 48.0% from baseline after 16 weeks (P < 0.001).
- All participants showed clinical improvement, with visible results starting by week 4 and progressing throughout the study.
- Statistically significant reductions were noted in dyschromia (31.2%), lines/wrinkles (27.3%), dryness/scaling (61.9%), and peeling (83.3%).
Conclusions:
- The 3-product topical Klotho regimen is safe, well-tolerated, and effective in treating multiple signs of photoaging.
- Early and progressive improvements in skin photodamage suggest that topical Klotho offers significant anti-aging benefits.
- The findings support further investigation into topical Klotho formulations for managing age-related skin concerns.